The global endoscopy market is a dynamic, billion-dollar market that is expected to grow through 2021. The market is also very saturated with intense competition due to the availability of similar product offerings across market players. In the face of increasing hospital consolidation into one network and the trend of oligopoly purchasing, i.e. purchasing more products from fewer manufacturers, the adoption pattern within the endoscopy space has become not entirely product performance based, but also strong brand awareness and identity has become a necessity. Going forward, the increasing emphasis placed on value and the concomitant need to demonstrate improved clinical outcomes will become a critical point of consideration for manufacturers, and will be the most significant factor shaping the design and development of new generation of endoscopic devices.
One of the largest sources of endoscopic demand originates from colorectal cancer screening and surveillance. Both colonoscopy and flexible sigmoidoscopy are accepted and recommended for colorectal cancer screening, along with aging population and clinical benefits of minimally invasive surgery, GlobalData expects these to be the main market drivers during the forecast period.
This report focuses on the global endoscopy market in the 10 major markets (US, France, Germany, Italy, Spain, UK, Japan, China, India, and Brazil). This report provides insight into the practice patterns and adoption trends, market dynamics, competitive landscape, marketed and pipeline products, current and emerging players, as well as market outlooks. The report identifies the unmet needs in the market while providing an understanding of physicians’ perceptions and decision-making processes in using and evaluating the adoption of different types of endoscopic devices.
About The Report
US, France, Germany, Italy, Spain, UK, Japan, Brazil, China, and India
Request Sample Pages